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TECHNICAL NOTE
Heat disinfection of polysulfone hemodialyzers
PATRICIA SCHOENFELD, MELODY D. MCLAUGHLIN, and MIcL MENDELSON
University of California Renal Center, San Francisco General Hospital University of California, San Francisco, California, USA
Reprocessing of hemodialyzers has been a clinical practice
since the beginning of chronic hemodialysis therapy in the 1960's.
This practice was performed initially with Kiil dialyzers for time
efficiency as well as cost of the membranes [1]. When the hollow
fiber dialyzer was developed at San Francisco General Hospital in
the late 1960's by Gotch et al [2], it was reused from the very
beginning because of shortages in dialyzer supply as well as cost
considerations [3]. As the hollow fiber dialyzer gradually became
the most widely used device, and cost decreased, there was a shift
away from reuse because of concern regarding the use of hazard-
ous chemicals and their potential for clinical complications in both
patients and staff. When synthetic, high flux membranes became
available in the 80's, cost again became a factor and reuse has
steadily grown in practice throughout the world except in those
countries where high dialysis reimbursement still allows for single
use.
Processing of dialyzers was initially a manual technique using
formalin for disinfection. Subsequently, automated systems with
computer monitoring were developed for dialyzer cleaning, test-
ing, disinfection, and documentation. Other chemical agents such
as peracetic acid, and glutaraldehyde are used clinically, but all
products currently on the market have physical hazards associated
with their handling by personnel and have been implicated in
clinical complications. Several types of adverse effects have been
associated with the reuse of dialyzers, although cause and effect
have not been clearly established in each case. These include
clusters of pyrogen reactions, local irritation of the blood vessels
due to residual chemicals, mycobacterial infections, and anaphy-
lactoid reactions in patients taking ACE inhibitors [4—7]. Re-
cently, the FDA and USRDS have reported two uncontrolled and
controversial studies which show an association between reuse of
dialyzers with certain germicides and an increased mortality [81.
As an alternative to chemical disinfection, heat disinfection has
been developed for use with Fresenius polysulfone dialyzers [9].
This process has been used in a limited fashion by several dialysis
centers [10] and has been standard reuse technology for all
patients at the University of California Renal Center since
September 1991. This report summarizes that experience in 103
patients over 15 months [11].
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Methods
Patients and dialyzers
A total of 12,530 treatments in 103 patients were performed
with heat disinfected dialyzers between 9/91 and 1/93 (Table 1).
This included all patients in the dialysis center except those who
were HBAg positive. Human immunodeficiency virus (HIV)
positive patients were treated the same as HIV negative patients.
All patients were treated with Fresenius high flux dialysis 2008
delivery systems and polysulfone dialyzers (F6,F60,F6OM,F80,
F8OM), as summarized in Table 2. The majority of patients
required high flux dialyzers, either F60 and F6OM, or F80 and
F8OM. The M series dialyzers have the same membrane biocom-
patibility and similar ultrafiltration characteristics to the standard
dialyzers, but have a tighter membrane structure that significantly
reduces middle molecule clearance such as /32-microglobulin, and
thus is not a true high flux dialyzer. M series dialyzers were used
initially with HD because they were manufactured with a heat
resistant resin that enabled the use of heat disinfection. This
resin material, which is modified to increase the hardness
of the material while decreasing the bonding of the resin to
dialyzer jacket, is now used in the manufacture of all Fresenius
dialyzers.
Time on dialysis (Td) averaged 6.7 hours per week with blood
flows of 400 to 480 ml/min and dialysate flows of 500 to 800 ml per
mi Heparinization was determined by heparin kinetics using
whole blood partial thromboplastin times in each patient, with a
target value of 150 seconds [12]. About 10% of patients were
receiving fixed low dose Coumadin therapy (1 to 2 mg/day) for
graft clotting problems. The effect of anticoagulant therapy on
reuse was not investigated in these studies. Dialysate composition
was Na 138, Cl 107, K 2.0, Ca 3.5, bicarbonate 35, and Mg 1.0
mEq/Iiter and glucose 200 mg/dl in most patients. Prescribed
KT/V was 1.2 per session, and was monitored clinically by
comparing the prescribed dialysis prescription to the actual
delivered KT/V in each patient every three months. Clinical
chemistries and KT/V were done monthly.
Dialyzer membrane performance was monitored for changes
with HD by measuring urea clearances using total dialysate
collection or a dialysate sampling module (DSM) that collects a
fixed fraction (1%) of dialysate flow before ultrafiltration volume
is added to the outflow volume. Pre- and post-serum and dialysate
samples were analyzed for urea nitrogen concentration. Urea
clearance (Kd urea) and KTIV was calculated using PackH, a
computer-assisted single pool model for urea kinetics. Effective
urea clearance (Kde) was then calculated as:
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Number
Age
Gender
Men
Women
Duration of dialysis therapy
Mean
Range
ESRD diagnosis
Nephrosclerosis
Diabetes
GN
Obstructive
SLE
APKD
HIV
Other
Unknown
Number
of
patients
Number
of
dialyses
Number
of
dialyzers
Average
reuse
F60 33 651 95 6.8
F6OM 77 4187 502 8.3
F80 40 954 144 6.6
F8OM 65 5698 761 7.5
F6 26 1Q40 156 6.8
Total 241 12,530 1658 7.2
kinetic volume
Kde
current volume (Kd)
Regression analyses of KT/V and effective urea clearance plotted
against number of reuses were performed to determine if heat
disinfection had a significant effect on membrane function and
clinical dialysis prescription (Fig. 1 A, B).
Reuse procedure
Maximum usage was initially set at 10 uses (initial plus 9 heat
cycles) and later increased to 11 uses on an arbitrary basis, as
further clinical experience was obtained with this technique.
Modifications in the protocol were necessitated because of pitting
and cracking of the dialyzer jacket, headers and ports. Several
different types of labels and glues were used in an attempt to
correct this problem, however, the substitution of RO for tap
water to rinse the casing and elimination of bleach from repro-
cessing eventually resulted in fewer casing problems. All dialyzers
were reprocessed in the dialyzer reuse room with a Seratronics
DRS4-ND dialyzer reprocessing system, retro-fitted for heat,
using computerized data management system version 4.19. The
DRS4-ND system performs the following steps during routine
operation:
1. Rinse
2. Reverse ultrafiltration
3. Test A (KUF) ultrafiltration
B Urea clearance with reuse
450—
400
350 • : :
300
250 • :
200
150
0 2 4 6 8 10 12
Number of reuses
Fig. 1. A. The relationship between calculated KT/V and number of dialyzer
reuses. In Ar = 0.27; P> 0.05. B. The relationship between urea clearance
measured from total dialysate collection and number of dialyzer reuses.
r = 0.21; P> 0.10.
4. Test B (TBV) total bundle volume
5. Test C (Leak) fiber/resin leak
6. Fill with sterilant or RO water for the HD process.
After rinsing, cleaning, and reprocessing, dialyzers are placed in
polyethylene bags containing a heat-sensitive indicator tag. The
bags heat seal on themselves during the heat process, but are
designed to serve as dust protector, not a sterile barrier. Each
dialyzer is sealed with locking caps on both the dialysate and
blood side and will remain disinfected indefinitely as long as the
caps are not removed. They are then heated in Baxter DK 63
constant temperature convection ovens to 105° for 20 hours
minimum and 36 hours maximum. Correct heating is monitored
by 24-hour temperature recording charts (Pacific Transducer
Corp., LA, CA, USA) as well as the color change on the heat
indicator tag inside the bag. Timing is controlled manually by
keeping careful chart records for each oven. Oven temperature
drops each time the door is opened, which is minimized by
processing dialyzers from each shift but not placing them in the
oven until a rack or oven is filled. In the event that the heat
reprocessing time is interrupted and the recommended minimum
time and temperature is not met, the dialyzers were reprocessed
according to the standard protocol. Dialyzers set up at a patient
station but not used were also reprocessed as above.
Heat disinfection
Typical heat or steam sterilization uses 121°C as the standard
for sterility practices. However, there is a direct relationship of the
Table 1. Heat disinfection patient characteristics A KT/V with reuse
2.5
2
>1.5
0.5
103
54 years (30—78)
60
43
33 months
1—192 months
32
25
9
5
4
4
3
6
15
2 4 6 8 10 12
Number of reuses
Table 2. Heat disinfection patient experience
E
G)
C.)
Cs
Cs
ci)
C.)
Cci
ci)
Kd urea =
actual KIT/V X current volume
t
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Table 3. Cause of dialyzer rejection by type
Type F60 % F80 % F6 % TOTAL %
N 513 34 876 57 140 9 1529 100
1. Max reuse 257 50 276 32 56 40 589 39
2. Technical
Casing leaks 191 37 311 36 56 40 558 36
DRS4 failure 29 6 161 18 12 8 202 13
Resin leaks 12 2 58 7 4 3 74 4
TBV failure 9 2 53 6 8 6 70 5
Cosmetic 15 3 7 1 4 3 26 2
Definitions of dialyzer failure categories are: Max reuse, dialyzer was used and/or reprocessed 11 times; Casing leaks, brittle or broken threads/wings
which prevented a tight seal when header or pressure caps were applied; DRS4 failure, dialyzer failed machine leak test; Resin leak, clinically observed
blood leak due to dialyzer potting material separation; TBV failure, dialyzer fiber bundle volume less than 80% of original value.
time, temperature and pressure used to sterilize materials [13].
With hemodialyzers, time can be increased up to 40 hours or
more for disinfection without interfering with routine three times
a week dialysis schedules. In addition, current AAMI Recom-
mended Practice for reuse of dialyzers does not call for steriliza-
tion but only disinfection of dialyzers between use [14]. Therefore,
a lower temperature can be used for longer exposure time at lower
pressure to achieve disinfection. The following shows the times
required for effective sterilization at various temperatures: 121°C
for 15 mm; 110°C for 190 mm; 105°C for 600 mm; 100°C for 1875
mm. These results are based on a 6 log reduction in population of
test organism B. stearothermophilus [9]. Equivalent killing at
105°C requires 40 minutes of exposure for every minute exposure
at 121 degrees. Thus, heating dialyzers to 105°C for 20 hours or
1200 minutes (± 2°C variation) allowed for sufficient time expo-
sure to assure disinfection and 20 hours fit into the typical
schedule for the dialysis unit.
In order to affirm disinfection of the dialyzers, samples of the
dialyzer fluid compartment from two to four dialyzers, from
different patients selected randomly, were sent for routine culture
each month. Fluid samples were taken just prior to dialyzer setup
for the next treatment and thus reflect the longest interval after
HD.
Set up of heat disinfected dialyzers
After heating, the bags are removed from the oven and cooled.
Prior to each use, the dialyzer is removed from the bag and
carefully inspected for leaks, cracks, or other casing problem. If
there is any standing fluid in the bag after heating, the dialyzer is
reprocessed and retested before clinical use. At the patient
station, a primed arterial and dry venous bloodline is attached to
the dialyzer which has had the dialysate side drained of fluid. The
dialysate side is then further tested by attaching an external
pressure gauge to the transducer protector attached to the venous
monitor line which keeps the blood side sterile during the
pressure test procedure. The blood side of the dialyzer is pressur-
ized until the pressure stabilizes to a minimum of 10 psi. The
pressure is observed for 30 seconds. A decline in pressure of no
more than 0.5 psi is considered adequate to exclude fiber or resin
leaks. If the dialyzer fails the pressure test, it is discarded.
Results
Performance characteristics
Calculation of urea clearance and KT/V using a single pool urea
model was performed monthly in conjunction with monthly blood
chemistries. KT/V was calculated using PackH software for the
PC or by Quantitative Medical Systems (Emeryville, CA, USA)
via modem. Analysis of these routine studies showed that the
delivered dialysis was usually very close to the prescribed KT!V
and was in agreement with data previously reported by Kaufman
et a! [10].
Forty-two patients had urea clearances measured by total
dialysate collections or DSM collections of 1% of dialysate flow.
Urea clearance, as well as KT/V calculated from these studies,
when plotted against dialyzer reuse showed no correlation with
number of reuses over the range of ito 11 (Fig. 1 A, B), indicating
that membrane function was not affected by repeated heating of
the dialyzer to 105°C.
Causes of dialyzer failure with heat disinfection
Dialyzers could potentially be rejected prior to maximum reuse
for either technical problems or patient care related reasons. The
technical causes of failure were divided into five categories as
summarized in Table 3.
Three to twenty percent of dialyzers were discarded due to
changes in patient medical care and were unrelated to technical
performance. These dialyzers were excluded from the total num-
ber at risk used in calculation of failure rates for each type of
dialyzer. A change in patient medical therapy, including dialysis
prescription or departure of the patient due to transfer, transplant
or death resulted in loss prior to maximum use in 2 to 10% of the
dialyzers, except for the F60. This dialyzer was discarded twenty
percent of the time because the dialysis prescription was changed
to an F80 to achieve the target KTIV.
F6OM and F8OM dialyzer data were combined with the stan-
dard dialyzer results for calculation of the overall results as there
were no significant differences between dialyzer types. Aside from
discards for maximum reuse standards, the most common cause of
failure was visible cracking, pitting, or leaks due to defects in the
headers and dialyzer ports, and overall 36% of all dialyzers were
rejected because of these casing integrity problems. Headers were
replaced if the crack was in the head, but defects in the threads
which prevented a tight seal resulted in loss of the dialyzer. Next
most common were fiber leaks or other defects which caused the
dialyzer to fail the leak test during DRS4 reprocessing or pressure
testing during the set-up procedure. Except for the F8OM, which
failed 21% of the time due to leaks during reprocessing, 13% of all
dialyzer types failed for this reason. Four percent of dialyzers
failed due to leaks in the resin potting material during dialysis
resulting in dialysate blood leak alarms for a total blood leak rate
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of 74 in 12,530 treatments (0.6%). A few of these leaks occurred
one to two hours into the dialysis run, but none were large enough
to be clinically alarming or associated with significant blood loss.
Clotting of the dialyzer or a loss of greater then 80% of the
original total fiber bundle volume was noted in 5% of all dialyzer
failures. A small number of dialyzers (2%) were rejected because
of poor cosmetic appearance due to retained blood in the fibers
and this problem seemed to be more common in the standard
dialyzers than in the M series.
Discussion
The results of the present study indicate that heat disinfection
of polysulfone dialyzers is both a safe and effective procedure for
reprocessing hemodialyzers. This procedure has a high accep-
tance rate among staff and patients alike, and can be accom-
plished without significant differences in time, but is somewhat
more costly than chemical disinfection. However, the positive
features of this process will probably outweigh the cost consider-
ations, especially when the disadvantages of chemical use are
gradually increasing.
Problems with chemical disinfection of dialyzers
While clinical complications with chemical disinfectants have
been minimal when good reuse standards are followed, there still
remains significant concern among patients and staff regarding
exposure to potentially toxic chemicals. Formaldehyde has been
the industry standard for many years, and when used in proper
concentrations is an effective and safe sterilant for dialyzers and
other equipment [12, 15, 16]. However, some dialysis staff develop
hypersensitivity to this agent, which results in clinical allergy and
inability to work with it in the patient care setting. Accidental
spills in clinical settings create potential hazards and inadvertent
mixing of formaldehyde and bleach can result in toxic fumes and
transient illness in staff and patients. Outbreaks of mycobacterial
infection were traced to the use of formaldehyde and Renalin in
subtherapeutic concentrations [5, 6], and clusters of pyrogen
reactions associated with the use of other chemical sterilants have
also been reported by the CDC [4]. Recently, the Federal Drug
Administration and the US Renal Data System reported an
association between increased mortality rates in dialysis patients
and the type of germicide used in dialyzer reprocessing [8]. One of
the studies conducted by the Urban Institute of Washington, D.C.,
with support from the Health Care Financing Administration,
showed an increased mortality rate among patients treated with
reprocessed dialyzers using either peracetic acid (Renalin) or
glutaraldehyde. Another study performed by the NIH showed
increased mortality rates only in patients using Renalin and
manual reuse techniques. While these reports are controversial
and do not claim to substantiate cause and effect for this
association, they do add to the general concern regarding the use
of chemical sterilants in the clinical dialysis setting.
Clinical experience
The greatest clinical advantage of HD is its apparent clinical
and technical safety. There were no pyrogen reactions or other
adverse effects in patients during the 15 months in which this data
was collected. Routine blood compartment cultures, obtained at
random on reprocessed dialyzers just before clinical use, showed
no significant bacterial contamination. The rate of dialyzer resin
blood leaks is slightly greater than with chemical disinfection,
however none of these has been large or clinically significant.
Dialyzer function has not been affected clinically and prescribed
KT/V is being delivered as measured by monthly urea kinetics.
Calculated KT/V and urea clearance and measured by dialysate
collection shows no change over the range of dialyzer uses [1—11],
indicating that membrane performance and small molecular
weight solute transport is not significantly altered by heat disin-
fection of polysulfone membranes under routine clinical condi-
tions (Fig. 1 A,B).
HD eliminates patient exposure to intravenous chemicals, it
improves the air quality of the dialysis unit, and limits staff use of
chemicals for specific equipment disinfection. Currently, in Cali-
fornia, all staff who handle hazardous chemicals must be fitted and
trained to use respirator masks, and annual documentation and
training records are required by Occupational Health and Safety
Codes. The use of HD for most equipment may make this aspect
of dialysis unit administration easier in the future. The benefits of
increased safety and reduction in chemical use could further be
realized in the reduction of building requirements and codes for
ventilation in dialysis centers. Decreased chemical use also re-
duces the ecological burden of chemicals in the environment and
sewage systems.
Staff acceptance
Acceptance of this technique by all staff members has been
exceptionally positive. The initial use of HD started with the
Monday, Wednesday and Friday patients but was quickly ex-
tended to the Tuesday, Thursday and Saturday shifts because of
noticeable difference in air quality in the unit. Adherence to the
increased number of steps needed for dialyzer reprocessing has
been excellent, which has limited the incidence of clinical prob-
lems and contributed to good technical results. The time needed
for reprocessing dialyzers with heat has been found to be slightly
shorter than with chemicals.
Limitations of heat sterilization
It has been demonstrated in some patients that heat processed
dialyzers may be reused up to 15 or more times; reuse during this
study was arbitrarily limited to 11 until greater experience has
been obtained with this technique to confirm its safety and
efficacy. The average number of reuses achieved by current
techniques is about 7 to 8, which is the major limiting factor to the
economic success of this technique. While the membrane appears
to tolerate the heat process well, the dialyzer casing is vulnerable
to cracking and leaks which are particularly troublesome in the
headers and dialysate ports. The potting resin is also somewhat
heat sensitive as there are more resin blood leaks noted with this
process than with chemical disinfection, although statistics are not
available to objectively compare the two methods. A stronger or
more heat resistant plastic material for the jacket would likely
reduce the incidence of these problems. Alternatively, longer
heating at lower temperatures may also offset some of the
heat-induced jacket integrity problems. Experience with heating
to 95 to 100°C in conjunction with the use of low level disinfectant
such as 1.5% citric acid has been obtained, and has resulted in an
increased use rate to 12 to 14 uses [17].
Fiber bundle clotting as reflected by TBV failures during DRS4
processing (Table 3) or poor cosmetic appearance has been quite
low with HD, suggesting that heat processing does not enhance
clotting of the dialyzer.
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A relative disadvantage is materials cost. There are initial
capital equipment costs for the ovens and pressure testing gauges;
however, the disposable supply costs are of more long-term
concern. They include replacement headers, heat indicator tags,
bags (which can be reused), and temperature recording charts.
These costs are partially offset by the lack of chemical expense
(formalin and bleach), residual formalin testing supplies, and less
saline needed for rinsing of dialyzers. After seven to eight uses,
the cost of the dialyzer is still a significant part of the total reuse
cost (supplies, labor, and equipment depreciation) which averages
$6.85 for heat, compared to $5.35 for bleach and formaldehyde
reuse in this facility.
Conclusions
In summary, HD is safe, easy to perform, and is an effective
means of dialyzer reprocessing and disinfection. Dialyzer perfor-
mance as measured by kinetic KT/V and measured urea clearance
do not show significant changes with HD. Current problems with
dialyzer jacket integrity which limits reuses, could probably be
addressed with either lower temperatures or modifications in
manufacturing materials. A combination of other less toxic ster-
ilants, that is, citric acid, plus heat may also be a practical means
to improve the number of uses and reduce costs. Even in its
current form, however, this technique is the method of choice for
staff and patients in our center and all would be extremely
reluctant to return to chemical disinfection.
Reprint requests to Patricia Schoenfeld, M.D., Department of Medicine,
UC Renal Center, Bldg. 100, R,n 350, San Francisco General Hospital, San
Francisco, California 94110, USA
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